111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
27.27B
The estimated revenue has decreased from the previous period.
4.49B
The estimated EBITDA has decreased from the previous period.
2.13
The estimated EPS has decreased from the previous period.
1.56B
The estimated net income has decreased from the previous period.
2.98B
The estimated EBIT has decreased from the previous period.
6.11B
The estimated SG&A expenses have decreased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
32.16B
Revenue has increased from the previous period.
12.30%
Revenue growth rate has increased from the previous period.
5.16B
EBITDA has increased from the previous period.
16.04%
EBITDA margin has increased from the previous period.
3.55B
EBIT has increased from the previous period.
11.03%
EBIT margin has increased from the previous period.
1.61B
Depreciation has decreased from the previous period.
6.00B
Total cash has decreased from the previous period.
18.67%
Cash percentage has decreased from the previous period.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
3.75B
Inventories have increased from the previous period.
11.66%
Inventory percentage has increased from the previous period.
2.83B
Accounts payable has increased from the previous period.
8.80%
Payables percentage has increased from the previous period.
-1.61B
Capital expenditure has increased from the previous period.
-5.02%
CapEx percentage has increased from the previous period.
9.67%
WACC has increased from the previous period.
10.90%
Cost of equity is unchanged from the previous period.
4.40%
Cost of debt is unchanged from the previous period.
1.38
Beta is unchanged from the previous period.
729.20M
Diluted shares outstanding is unchanged from the previous period.
13.52B
Total debt is unchanged from the previous period.
68.33B
Total equity is unchanged from the previous period.
81.85B
Total capital is unchanged from the previous period.
16.51%
Debt weighting is unchanged from the previous period.
83.49%
Equity weighting is unchanged from the previous period.
2.79B
EBIAT has increased from the previous period.
2.86B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
56.34B
Terminal value is unchanged from the previous period.
50.68B
Enterprise value has decreased from the previous period.
6.94B
Net debt is unchanged from the previous period.
43.74B
Equity value has decreased from the previous period.
59.98
Equity value per share has decreased from the previous period.
